Xpress Biologics
BelgiumEntry
2021
Hold
1yr
Exit
2022
Who owns Xpress Biologics?
Xpress Biologics is a Belgian Biotech company, now owned by Polyplus, which acquired it in 2022 from ARCHIMED.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Exit Type
Trade Sale
Buyer
Polyplus (ARCHIMED portfolio company at the time, intra-portfolio)
Exit Year
2022
More from MED III
Other portfolio companies in the same fund.
Denmark
US
GermanyMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Xpress Biologics?
Xpress Biologics is now owned by Polyplus, which acquired it in 2022 from ARCHIMED.
When did Polyplus acquire Xpress Biologics?
Polyplus acquired Xpress Biologics in 2022, buying from ARCHIMED.
Who did Xpress Biologics sell to?
ARCHIMED sold Xpress Biologics to Polyplus in 2022 (Trade Sale).
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue